74JPY
4.72 BJPY
113.27 BJPY
31.79 M
About KYORIN PHARMACEUTICAL CO LTD
Sector
Headquarters
Tokyo
Employees (FY)
2.14 K
Website
Founded
1958
ISIN
JP3247090008
FIGI
BBG000N1VDS8
KYORIN Pharmaceutical Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products through its subsidiaries. It operates through the Pharmaceutical Business and Healthcare Business segments. The Pharmaceutical Business segment engages in the production and sales of prescription drugs, generic drugs, and over the counter drugs. The Healthcare Business segment engages in the development and sales of skincare and cosmetics using drug formulation technology. The company was founded on October 31, 1958 and is headquartered in Tokyo, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4569 is 1778 JPY — it has decreased by 0.89% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange KYORIN PHARMACEUTICAL CO LTD stocks are traded under the ticker 4569.
KYORIN PHARMACEUTICAL CO LTD is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
4569 stock is 1.76% volatile and has beta coefficient of 0.38. Check out the list of the most volatile stocks — is KYORIN PHARMACEUTICAL CO LTD there?
One year price forecast for KYORIN PHARMACEUTICAL CO LTD has a max estimate of 2000 JPY and a min estimate of 1500 JPY.
Yes, you can track KYORIN PHARMACEUTICAL CO LTD financials in yearly and quarterly reports right on TradingView.
4569 stock has fallen by 2.84% compared to the previous week, the month change is a 0.39% fall, over the last year KYORIN PHARMACEUTICAL CO LTD has showed a 3.25% increase.
4569 net income for the last quarter is 2.16 B JPY, while the quarter before that showed 1.08 B JPY of net income which accounts for 99.54% change. Track more KYORIN PHARMACEUTICAL CO LTD financial stats to get the full picture.
Today KYORIN PHARMACEUTICAL CO LTD has the market capitalization of 102.66 B, it has increased by 1.62% over the last week.
KYORIN PHARMACEUTICAL CO LTD dividend yield was 3.05% in 2022, and payout ratio reached 63.09%. The year before the numbers were 2.93% and 75.78% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 4569 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KYORIN PHARMACEUTICAL CO LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 2.14 K employees. See our rating of the largest employees — is KYORIN PHARMACEUTICAL CO LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KYORIN PHARMACEUTICAL CO LTD technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KYORIN PHARMACEUTICAL CO LTD stock shows the sell signal. See more of KYORIN PHARMACEUTICAL CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on KYORIN PHARMACEUTICAL CO LTD future price: according to them, 4569 price has a max estimate of 2000.00 JPY and a min estimate of 1500.00 JPY. Read a more detailed KYORIN PHARMACEUTICAL CO LTD forecast: see what analysts think of KYORIN PHARMACEUTICAL CO LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KYORIN PHARMACEUTICAL CO LTD EBITDA is 9.09 B JPY, and current EBITDA margin is 7.91%. See more stats in KYORIN PHARMACEUTICAL CO LTD financial statements.